QR-Code

Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study

Abstract Introduction Guselkumab previously showed greater improvements versus placebo in axial symptoms in patients with psoriatic arthritis (PsA) (assessed by Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] and Ankylosing Spondylitis Disease Activity Score [ASDAS]), in post hoc analyse...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Philip J. Mease, Dafna D. Gladman, Denis Poddubnyy, Soumya D. Chakravarty, May Shawi, Alexa P. Kollmeier, Xie L. Xu, Stephen Xu, Atul Deodhar, Xenofon Baraliakos
Format: Artigo
Sprache:Inglês
Veröffentlicht: Adis, Springer Healthcare 2023-10-01
Schriftenreihe:Rheumatology and Therapy
Schlagworte:
Psoriatic arthritis
Axial
Biologics
Guselkumab
Online-Zugang:https://doi.org/10.1007/s40744-023-00592-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge